HNN3.0
Register
Register
Register

BioTalentum

Company (SME)

biotalentum.euGodollo, Hungary
6 profile visits

About

BioTalentum Ltd has been established in 2005, and the leading Hungarian company in the field of human induced pluripotent stem cell based regenerative medicine, in vitro disease modelling and in vitro drug/chemical toxicity assays. BIOT is very active in international collaborations, including EU Framework projects (13 coordination of 30+ completed and ongoing projects, IHI and national projects). We have ongoing projects on T1D beta cell therapy (preclinical stage), and ASO gene therapy for ultra rare diseases. For details please visit www.biotalentum.eu .

Representatives

Co-founder and General Director

BioTalentum

Marketplace (2)

  • Project cooperation

    New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

    Matching the "-Tool-03 and 06" calls: NAMs development and applications for biomedical research and testing of medicinal products/devices

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
    Author

    Co-founder and General Director at BioTalentum

    Godollo, Hungary

  • Project cooperation

    Regenerative medicine ATMPs for T1D

    Matching Tool-05, -07: Developing ATMPs for regenerative medicine solution on Type-1 diabetes

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
    Author

    Co-founder and General Director at BioTalentum

    Godollo, Hungary